DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells

In various human malignancies, widespread dysregulation of microRNA (miRNA) expression is reported to occur and affects various cell growth programs. Recent studies suggest that the expression levels of miRNAs that act as tumor suppressors are frequently reduced in cancers because of chromosome dele...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta 2013-10, Vol.1829 (10), p.1102-1110
Hauptverfasser: Iio, Akio, Takagi, Takeshi, Miki, Kohei, Naoe, Tomoki, Nakayama, Atsuo, Akao, Yukihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1110
container_issue 10
container_start_page 1102
container_title Biochimica et biophysica acta
container_volume 1829
creator Iio, Akio
Takagi, Takeshi
Miki, Kohei
Naoe, Tomoki
Nakayama, Atsuo
Akao, Yukihiro
description In various human malignancies, widespread dysregulation of microRNA (miRNA) expression is reported to occur and affects various cell growth programs. Recent studies suggest that the expression levels of miRNAs that act as tumor suppressors are frequently reduced in cancers because of chromosome deletions, epigenetical changes, aberrant transcription, and disturbances in miRNA processing. MiR-143 and -145 are well-recognized miRNAs that are highly expressed in several tissues, but down-regulated in most types of cancers. However, the mechanism of this down-regulation has not been investigated in detail. Here, we show that DEAD-box RNA helicase 6, DDX6 (p54/RCK), post-transcriptionally down-regulated miR-143/145 expression by prompting the degradation of its host gene product, NCR143/145 RNA. In human gastric cancer cell line MKN45, DDX6 protein was abundantly expressed and accumulated in processing bodies (P-bodies). DDX6 preferentially increased the instability of non-coding RNA, NCR143/145, which encompasses the miR-143/145 cluster, and down-regulated the expression of mature miR-143/145. In human monocytic cell line THP-1, lipopolysaccharide treatment promoted the assembly of P-bodies and down-regulated the expression of NCR143/145 and its miR-143/145 rapidly. In these cells, cycloheximide treatment led to a loss of P-bodies and to an increase in NCR143/145 RNA stability, thus resulting in up-regulation of miR-143/145 expression. These data demonstrate that DDX6 contributed to the control of NCR143/145 RNA stability in P-bodies and post-transcriptionally regulated miR-143/145 expression in cancer cells. •DDX6 highly expressed in stomach cancer tissues.•DDX6 post-transcriptionally down-regulated miR-143/145 host gene, NCR143/145.•The expression levels of NCR143/145 and miR-143/145 were dependent on the presence of P-bodies.•DDX6 had significant effects on the degradation of NCR143/145 RNA in the cytoplasm.•DDX6 promoted NCR143/145 RNA degradation through decapping followed by miR-143/145 down-regulation.
doi_str_mv 10.1016/j.bbagrm.2013.07.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1500783688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1874939913001211</els_id><sourcerecordid>1433274367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-a99e8c172cd66cda445f4daa89fbd0d19bf14c8f41960291534b20467cfd70223</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EoqXwDxDykUvSGdvrxBcktOVLqkCqQOJmOfZk16t8YSeF_nuybMsRTjOH550ZzcPYS4QSAfXloWwat0t9KQBlCVUJCI_YOdaVLpQU8PhPrwojjTljz3I-AGgUAE_ZmZBGCiPwnA1XV981n8Y8F3NyQ_YpTnMcB9d1dzyMP4ci0W7p3EyZ9_GmQCUvUW04_ZoS5bySfN6ncdnt-X4dwnc0EP-8vXng4sC9Gzwl7qnr8nP2pHVdphf39YJ9e__u6_Zjcf3lw6ft2-vCK41z4Yyh2mMlfNDaB6fUplXBudq0TYCApmlR-bpVaDQIgxupGgFKV74NFQghL9jr09wpjT8WyrPtYz5e4AYal2xxA1DVUtf1_1ElpaiU1NWKqhPq05hzotZOKfYu3VkEe5RiD_YkxR6lWKjsKmWNvbrfsDQ9hb-hBwsr8OYE0PqS20jJZh9p_VqIifxswxj_veE3MB6dJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1433274367</pqid></control><display><type>article</type><title>DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Iio, Akio ; Takagi, Takeshi ; Miki, Kohei ; Naoe, Tomoki ; Nakayama, Atsuo ; Akao, Yukihiro</creator><creatorcontrib>Iio, Akio ; Takagi, Takeshi ; Miki, Kohei ; Naoe, Tomoki ; Nakayama, Atsuo ; Akao, Yukihiro</creatorcontrib><description>In various human malignancies, widespread dysregulation of microRNA (miRNA) expression is reported to occur and affects various cell growth programs. Recent studies suggest that the expression levels of miRNAs that act as tumor suppressors are frequently reduced in cancers because of chromosome deletions, epigenetical changes, aberrant transcription, and disturbances in miRNA processing. MiR-143 and -145 are well-recognized miRNAs that are highly expressed in several tissues, but down-regulated in most types of cancers. However, the mechanism of this down-regulation has not been investigated in detail. Here, we show that DEAD-box RNA helicase 6, DDX6 (p54/RCK), post-transcriptionally down-regulated miR-143/145 expression by prompting the degradation of its host gene product, NCR143/145 RNA. In human gastric cancer cell line MKN45, DDX6 protein was abundantly expressed and accumulated in processing bodies (P-bodies). DDX6 preferentially increased the instability of non-coding RNA, NCR143/145, which encompasses the miR-143/145 cluster, and down-regulated the expression of mature miR-143/145. In human monocytic cell line THP-1, lipopolysaccharide treatment promoted the assembly of P-bodies and down-regulated the expression of NCR143/145 and its miR-143/145 rapidly. In these cells, cycloheximide treatment led to a loss of P-bodies and to an increase in NCR143/145 RNA stability, thus resulting in up-regulation of miR-143/145 expression. These data demonstrate that DDX6 contributed to the control of NCR143/145 RNA stability in P-bodies and post-transcriptionally regulated miR-143/145 expression in cancer cells. •DDX6 highly expressed in stomach cancer tissues.•DDX6 post-transcriptionally down-regulated miR-143/145 host gene, NCR143/145.•The expression levels of NCR143/145 and miR-143/145 were dependent on the presence of P-bodies.•DDX6 had significant effects on the degradation of NCR143/145 RNA in the cytoplasm.•DDX6 promoted NCR143/145 RNA degradation through decapping followed by miR-143/145 down-regulation.</description><identifier>ISSN: 1874-9399</identifier><identifier>ISSN: 0006-3002</identifier><identifier>EISSN: 1876-4320</identifier><identifier>DOI: 10.1016/j.bbagrm.2013.07.010</identifier><identifier>PMID: 23932921</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Blotting, Western ; Cells, Cultured ; DDX6 ; DEAD-box RNA Helicases - antagonists &amp; inhibitors ; DEAD-box RNA Helicases - genetics ; DEAD-box RNA Helicases - metabolism ; Fluorescent Antibody Technique ; Gene Expression Regulation ; Humans ; Luciferases - metabolism ; Male ; MicroRNAs - antagonists &amp; inhibitors ; MicroRNAs - genetics ; miR-143 ; miR-145 ; Monocytes - cytology ; Monocytes - metabolism ; NCR143/145 ; P-bodies ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - metabolism ; Proto-Oncogene Proteins - antagonists &amp; inhibitors ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; RNA Processing, Post-Transcriptional ; RNA, Long Noncoding - genetics ; RNA, Messenger - genetics ; RNA, Small Interfering - genetics ; Stomach Neoplasms - genetics ; Stomach Neoplasms - metabolism</subject><ispartof>Biochimica et biophysica acta, 2013-10, Vol.1829 (10), p.1102-1110</ispartof><rights>2013 Elsevier B.V.</rights><rights>2013.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-a99e8c172cd66cda445f4daa89fbd0d19bf14c8f41960291534b20467cfd70223</citedby><cites>FETCH-LOGICAL-c461t-a99e8c172cd66cda445f4daa89fbd0d19bf14c8f41960291534b20467cfd70223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1874939913001211$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23932921$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iio, Akio</creatorcontrib><creatorcontrib>Takagi, Takeshi</creatorcontrib><creatorcontrib>Miki, Kohei</creatorcontrib><creatorcontrib>Naoe, Tomoki</creatorcontrib><creatorcontrib>Nakayama, Atsuo</creatorcontrib><creatorcontrib>Akao, Yukihiro</creatorcontrib><title>DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells</title><title>Biochimica et biophysica acta</title><addtitle>Biochim Biophys Acta</addtitle><description>In various human malignancies, widespread dysregulation of microRNA (miRNA) expression is reported to occur and affects various cell growth programs. Recent studies suggest that the expression levels of miRNAs that act as tumor suppressors are frequently reduced in cancers because of chromosome deletions, epigenetical changes, aberrant transcription, and disturbances in miRNA processing. MiR-143 and -145 are well-recognized miRNAs that are highly expressed in several tissues, but down-regulated in most types of cancers. However, the mechanism of this down-regulation has not been investigated in detail. Here, we show that DEAD-box RNA helicase 6, DDX6 (p54/RCK), post-transcriptionally down-regulated miR-143/145 expression by prompting the degradation of its host gene product, NCR143/145 RNA. In human gastric cancer cell line MKN45, DDX6 protein was abundantly expressed and accumulated in processing bodies (P-bodies). DDX6 preferentially increased the instability of non-coding RNA, NCR143/145, which encompasses the miR-143/145 cluster, and down-regulated the expression of mature miR-143/145. In human monocytic cell line THP-1, lipopolysaccharide treatment promoted the assembly of P-bodies and down-regulated the expression of NCR143/145 and its miR-143/145 rapidly. In these cells, cycloheximide treatment led to a loss of P-bodies and to an increase in NCR143/145 RNA stability, thus resulting in up-regulation of miR-143/145 expression. These data demonstrate that DDX6 contributed to the control of NCR143/145 RNA stability in P-bodies and post-transcriptionally regulated miR-143/145 expression in cancer cells. •DDX6 highly expressed in stomach cancer tissues.•DDX6 post-transcriptionally down-regulated miR-143/145 host gene, NCR143/145.•The expression levels of NCR143/145 and miR-143/145 were dependent on the presence of P-bodies.•DDX6 had significant effects on the degradation of NCR143/145 RNA in the cytoplasm.•DDX6 promoted NCR143/145 RNA degradation through decapping followed by miR-143/145 down-regulation.</description><subject>Blotting, Western</subject><subject>Cells, Cultured</subject><subject>DDX6</subject><subject>DEAD-box RNA Helicases - antagonists &amp; inhibitors</subject><subject>DEAD-box RNA Helicases - genetics</subject><subject>DEAD-box RNA Helicases - metabolism</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>Luciferases - metabolism</subject><subject>Male</subject><subject>MicroRNAs - antagonists &amp; inhibitors</subject><subject>MicroRNAs - genetics</subject><subject>miR-143</subject><subject>miR-145</subject><subject>Monocytes - cytology</subject><subject>Monocytes - metabolism</subject><subject>NCR143/145</subject><subject>P-bodies</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Proto-Oncogene Proteins - antagonists &amp; inhibitors</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Real-Time Polymerase Chain Reaction</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA Processing, Post-Transcriptional</subject><subject>RNA, Long Noncoding - genetics</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Small Interfering - genetics</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - metabolism</subject><issn>1874-9399</issn><issn>0006-3002</issn><issn>1876-4320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EoqXwDxDykUvSGdvrxBcktOVLqkCqQOJmOfZk16t8YSeF_nuybMsRTjOH550ZzcPYS4QSAfXloWwat0t9KQBlCVUJCI_YOdaVLpQU8PhPrwojjTljz3I-AGgUAE_ZmZBGCiPwnA1XV981n8Y8F3NyQ_YpTnMcB9d1dzyMP4ci0W7p3EyZ9_GmQCUvUW04_ZoS5bySfN6ncdnt-X4dwnc0EP-8vXng4sC9Gzwl7qnr8nP2pHVdphf39YJ9e__u6_Zjcf3lw6ft2-vCK41z4Yyh2mMlfNDaB6fUplXBudq0TYCApmlR-bpVaDQIgxupGgFKV74NFQghL9jr09wpjT8WyrPtYz5e4AYal2xxA1DVUtf1_1ElpaiU1NWKqhPq05hzotZOKfYu3VkEe5RiD_YkxR6lWKjsKmWNvbrfsDQ9hb-hBwsr8OYE0PqS20jJZh9p_VqIifxswxj_veE3MB6dJQ</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Iio, Akio</creator><creator>Takagi, Takeshi</creator><creator>Miki, Kohei</creator><creator>Naoe, Tomoki</creator><creator>Nakayama, Atsuo</creator><creator>Akao, Yukihiro</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201310</creationdate><title>DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells</title><author>Iio, Akio ; Takagi, Takeshi ; Miki, Kohei ; Naoe, Tomoki ; Nakayama, Atsuo ; Akao, Yukihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-a99e8c172cd66cda445f4daa89fbd0d19bf14c8f41960291534b20467cfd70223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Blotting, Western</topic><topic>Cells, Cultured</topic><topic>DDX6</topic><topic>DEAD-box RNA Helicases - antagonists &amp; inhibitors</topic><topic>DEAD-box RNA Helicases - genetics</topic><topic>DEAD-box RNA Helicases - metabolism</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>Luciferases - metabolism</topic><topic>Male</topic><topic>MicroRNAs - antagonists &amp; inhibitors</topic><topic>MicroRNAs - genetics</topic><topic>miR-143</topic><topic>miR-145</topic><topic>Monocytes - cytology</topic><topic>Monocytes - metabolism</topic><topic>NCR143/145</topic><topic>P-bodies</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Proto-Oncogene Proteins - antagonists &amp; inhibitors</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Real-Time Polymerase Chain Reaction</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA Processing, Post-Transcriptional</topic><topic>RNA, Long Noncoding - genetics</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Small Interfering - genetics</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iio, Akio</creatorcontrib><creatorcontrib>Takagi, Takeshi</creatorcontrib><creatorcontrib>Miki, Kohei</creatorcontrib><creatorcontrib>Naoe, Tomoki</creatorcontrib><creatorcontrib>Nakayama, Atsuo</creatorcontrib><creatorcontrib>Akao, Yukihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Biochimica et biophysica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iio, Akio</au><au>Takagi, Takeshi</au><au>Miki, Kohei</au><au>Naoe, Tomoki</au><au>Nakayama, Atsuo</au><au>Akao, Yukihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells</atitle><jtitle>Biochimica et biophysica acta</jtitle><addtitle>Biochim Biophys Acta</addtitle><date>2013-10</date><risdate>2013</risdate><volume>1829</volume><issue>10</issue><spage>1102</spage><epage>1110</epage><pages>1102-1110</pages><issn>1874-9399</issn><issn>0006-3002</issn><eissn>1876-4320</eissn><abstract>In various human malignancies, widespread dysregulation of microRNA (miRNA) expression is reported to occur and affects various cell growth programs. Recent studies suggest that the expression levels of miRNAs that act as tumor suppressors are frequently reduced in cancers because of chromosome deletions, epigenetical changes, aberrant transcription, and disturbances in miRNA processing. MiR-143 and -145 are well-recognized miRNAs that are highly expressed in several tissues, but down-regulated in most types of cancers. However, the mechanism of this down-regulation has not been investigated in detail. Here, we show that DEAD-box RNA helicase 6, DDX6 (p54/RCK), post-transcriptionally down-regulated miR-143/145 expression by prompting the degradation of its host gene product, NCR143/145 RNA. In human gastric cancer cell line MKN45, DDX6 protein was abundantly expressed and accumulated in processing bodies (P-bodies). DDX6 preferentially increased the instability of non-coding RNA, NCR143/145, which encompasses the miR-143/145 cluster, and down-regulated the expression of mature miR-143/145. In human monocytic cell line THP-1, lipopolysaccharide treatment promoted the assembly of P-bodies and down-regulated the expression of NCR143/145 and its miR-143/145 rapidly. In these cells, cycloheximide treatment led to a loss of P-bodies and to an increase in NCR143/145 RNA stability, thus resulting in up-regulation of miR-143/145 expression. These data demonstrate that DDX6 contributed to the control of NCR143/145 RNA stability in P-bodies and post-transcriptionally regulated miR-143/145 expression in cancer cells. •DDX6 highly expressed in stomach cancer tissues.•DDX6 post-transcriptionally down-regulated miR-143/145 host gene, NCR143/145.•The expression levels of NCR143/145 and miR-143/145 were dependent on the presence of P-bodies.•DDX6 had significant effects on the degradation of NCR143/145 RNA in the cytoplasm.•DDX6 promoted NCR143/145 RNA degradation through decapping followed by miR-143/145 down-regulation.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23932921</pmid><doi>10.1016/j.bbagrm.2013.07.010</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1874-9399
ispartof Biochimica et biophysica acta, 2013-10, Vol.1829 (10), p.1102-1110
issn 1874-9399
0006-3002
1876-4320
language eng
recordid cdi_proquest_miscellaneous_1500783688
source MEDLINE; Elsevier ScienceDirect Journals
subjects Blotting, Western
Cells, Cultured
DDX6
DEAD-box RNA Helicases - antagonists & inhibitors
DEAD-box RNA Helicases - genetics
DEAD-box RNA Helicases - metabolism
Fluorescent Antibody Technique
Gene Expression Regulation
Humans
Luciferases - metabolism
Male
MicroRNAs - antagonists & inhibitors
MicroRNAs - genetics
miR-143
miR-145
Monocytes - cytology
Monocytes - metabolism
NCR143/145
P-bodies
Prostatic Neoplasms - genetics
Prostatic Neoplasms - metabolism
Proto-Oncogene Proteins - antagonists & inhibitors
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
RNA Processing, Post-Transcriptional
RNA, Long Noncoding - genetics
RNA, Messenger - genetics
RNA, Small Interfering - genetics
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
title DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A38%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DDX6%20post-transcriptionally%20down-regulates%20miR-143/145%20expression%20through%20host%20gene%20NCR143/145%20in%20cancer%20cells&rft.jtitle=Biochimica%20et%20biophysica%20acta&rft.au=Iio,%20Akio&rft.date=2013-10&rft.volume=1829&rft.issue=10&rft.spage=1102&rft.epage=1110&rft.pages=1102-1110&rft.issn=1874-9399&rft.eissn=1876-4320&rft_id=info:doi/10.1016/j.bbagrm.2013.07.010&rft_dat=%3Cproquest_cross%3E1433274367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1433274367&rft_id=info:pmid/23932921&rft_els_id=S1874939913001211&rfr_iscdi=true